TARGETING SPHINGOSINE KINASE 2 WITH THE NOVEL COMPOUND ABC294640 IN PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Qudeimat, Amr [1 ]
Li, Li [1 ]
Rahamanyian, Mehrdad [1 ]
Prudowsky, Zachary D. [1 ]
Smith, Charles [1 ]
Kraveka, Jacqueline [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer
    Yang, Jie
    Yang, Chunxu
    Zhang, Shimin
    Mei, Zijie
    Shi, Mingjun
    Sun, Shaoxing
    Shi, Liu
    Wang, Zhihao
    Wang, Yacheng
    Li, Zhenzhen
    Xie, Conghua
    CANCER BIOLOGY & THERAPY, 2015, 16 (08) : 1194 - 1204
  • [22] INHIBITION OF SPHINGOSINE KINASE-2 BY ABC294640 SUPPRESSES ENDOTOXIN-INDUCED INFLAMMATORY RESPONSES AND APOPTOSIS IN MOUSE LIVERS
    Krishnasamy, Yasodha
    Lemasters, John J.
    Zhong, Zhi
    GASTROENTEROLOGY, 2017, 152 (05) : S1045 - S1046
  • [23] Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640
    Lewis, Clayton S.
    Voelkel-Johnson, Christina
    Smith, Charles D.
    ONCOTARGET, 2016, 7 (37) : 60181 - 60192
  • [24] The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo
    Dai, Lu
    Smith, Charles D.
    Foroozesh, Maryam
    Miele, Lucio
    Qin, Zhiqiang
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (10) : 2153 - 2162
  • [25] Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression
    Leili, Hasanifard
    Nasser, Samadi
    Nadereh, Rashtchizadeh
    Siavoush, Dastmalchi
    Pouran, Karimi
    DRUG RESEARCH, 2018, 68 (01) : 45 - 53
  • [26] Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells
    Zhang, Fei
    Hu, Wenqi
    Qu, Lili
    Cang, Chunlei
    CHANNELS, 2020, 14 (01) : 216 - 230
  • [27] Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
    McNaughton, Melissa
    Pitman, Melissa
    Pitson, Stuart M.
    Pyne, Nigel J.
    Pyne, Susan
    ONCOTARGET, 2016, 7 (13) : 16663 - 16675
  • [28] Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression (vol 68, pg 45, 2018)
    Hasanifard, Leili
    Samadi, Nasser
    Rashtchizadeh, Nadereh
    Dastmalchi, Siavoush
    Karimi, Pouran
    DRUG RESEARCH, 2018, 68 (01) : E1 - E1
  • [29] The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation
    Sundaramoorthy, Pasupathi
    Gasparetto, Cristina
    Kang, Yubin
    CANCER MEDICINE, 2018, 7 (07): : 3257 - 3268
  • [30] Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression
    Schrecengost, Randy S.
    Keller, Staci N.
    Schiewer, Matthew J.
    Knudsen, Karen E.
    Smith, Charles D.
    MOLECULAR CANCER RESEARCH, 2015, 13 (12) : 1591 - 1601
12345